ACADIA PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Acadia Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.84M, a 76.2% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $6.85M, a 72.8% decline from 2023.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $25.1M, a 206% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.2M, a 54.9% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ACADIA PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.84M +$795K +76.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $1.04M -$423K -28.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $1.47M -$1M -40.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $2.47M -$5.26M -68.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $7.73M +$3.97M +106% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $3.75M -$422K -10.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $4.18M +$1.3M +45% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $2.88M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2013 $208K +$186K +845% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-07
Q1 2012 $22K -$13.8M -99.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q1 2011 $13.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08

ACADIA PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.85M -$18.3M -72.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $25.1M +$16.9M +206% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $8.2M -$9.96M -54.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $18.2M -$62.8M -77.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $81M -$291M -78.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $372M +$65.2M +21.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $307M +$275M +883% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $31.2M -$503M -94.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $534M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2012 $98.2M +$84.2M +604% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-12
2011 $13.9M +$13.5M +2867% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-12
2010 $470K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.